Attenuation of experimentally-induced amnesia.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000647:Amnesia / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D000661:Amphetamine / Q000627:therapeutic use*; D000818:Animals; D000841:Anisomycin / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004195:Disease Models, Animal; D004597:Electroshock; D004986:Ether / Q000627:therapeutic use*; D005019:Ethyl Ethers / Q000627:therapeutic use*; D006801:Humans; D007858:Learning / Q000187:drug effects*; D008781:Methyltyrosines / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D014176:Protein Biosynthesis / Q000187:drug effects; D011691:Puromycin / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013331:Strychnine / Q000627:therapeutic use*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D014667:Vasopressins / Q000627:therapeutic use*; D019805:alpha-Methyltyrosine
D005019:Ethyl Ethers; D008781:Methyltyrosines; D004986:Ether; D010643:Phenoxybenzamine; D014667:Vasopressins; D011691:Puromycin; D019805:alpha-Methyltyrosine; D000841:Anisomycin; D012110:Reserpine; D000324:Adrenocorticotropic Hormone; D003513:Cycloheximide; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D013331:Strychnine